novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
A:Critical Treatment in Critical Period + Ankylosaurus
B:Critical Treatment in Critical Period + Ankylosaurus+M1 suppression therapy
C:Critical Treatment in Critical Period
Sponsors
Affiliated Zhongshan Hospital of Dalian University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 2019-nCoV infected patients treated at Affiliated Zhongshan Hospital of Dalian University and Zhongnan Hospital of Wuhan University from January 2020 to December 2020 2. nCoV nucleic acid positive; 3. Aged >=18 years; 4. Patients understand the purpose of the trial, voluntarily sign informed consent, and agree to complete the rectification research process.
Exclusion criteria
Exclusion criteria: 1. Those with allergies; 2. Patients with a history of severe cardio-cerebral vascular disease, diabetes, mental and neurological diseases, severe liver and renal insufficiency; 3. History of hip or knee trauma or surgery; 4. Patients who abuse drugs; 5. Those who are in the acute phase of chronic diseases; 6. Patients with other malignant diseases and a survival time of less than 12 months; 7. pregnancy,lactating women; 8. Poor compliance and unable to follow up on time; 9. Participants in clinical trials of other drugs or devices within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT of lung;CT and MRI of hip; | — |
Countries
China
Contacts
Public ContactDewei Zhao
Affiliated Zhongshan Hospital of Dalian University
Outcome results
None listed